Proximity-Informed Graph Learning Defines Spatial Protein Communities for Tumor-Associated Proximity Antigen Discovery
Scandore, C.; Malone, C. F.; May, C. K.; de Regt, A. K.; Guernsey, J.; Ma, H.; Dephoure, N.; Setter, B.; Howell, R. A.; Johnson, K. R.; Farr, C. L.; Romero, S.; Vignale, L.; Vittum, T.; Dawson, E.; Habtetsion, T.; Nardi, F.; Woodruff, B.; Mathay, M.; Swanson, J.; Ton, Q.; Farahani, P. E.; Gene, R. W.; Misurelli, J.; Caldwell, Z.; Xu, H.; Hornsby, M.; Gavin, M. A.; Klock, H. E.; Eryilmaz, E.; Holland, P. M.; Lesley, S. A.; Oslund, R. C.; Fadeyi, O. O.
Show abstract
The spatial organization of membrane proteins is an underexplored dimension of cell-surface biology. Spatial proximity shapes cellular function and therapeutic targetability, yet efforts to identify tumor-associated antigens (TAAs) have largely focused on expression alone. Here, we developed an industrialized surface-protein proximity mapping workflow to interrogate TAAs within their membrane microenvironments. In the process, we generated 248 proximity maps across 12 receptor tyrosine kinases (RTKs) and 28 tumor cell systems. This proximity atlas enabled two advances: first, MetaMap, a correlation-based analytical framework that defines spatial protein communities and infers non-targeted proximal proteins from reproducible proximity signatures; and second, tumor-associated proximity antigens (TAPAs), a conceptual class of co-targets defined by disease-specific spatial proximity to TAAs rather than expression alone. Applying these proximity-derived relationships within a multimodal prioritization framework, we identified and validated an EGFRxCDCP1 TAA-TAPA pair that enhanced tumor cell killing across therapeutic modalities. By integrating spatial organization with multimodal data, this work expands the design space for precision-guided therapeutic strategies.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Multi-modal digital pathology for colorectal cancer diagnosis by high-plex immunofluorescence imaging and traditional histology of the same tissue section 97%
- Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response 96%
- Non-oncology drugs are a source of previously unappreciated anti-cancer activity 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.